Hester Biosciences appoints Ashish Desai as new chief financial officer

Hester Biosciences has appointed Ashish Desai as its new chief financial officer (CFO) and key managerial personnel, effective November 20, 2025. Desai, currently the group finance controller, will assume the CFO role after the board of directors approved the appointment through a circulation resolution, based on recommendations from the nomination and remuneration committee and the audit committee.

Desai brings over 25 years of experience in finance, accounting, and taxation, holding a chartered accountant qualification and a bachelor's degree in commerce. His prior roles include serving as CFO at Blue Ray Aviation Private Limited and at Shreeyam Power & Steel Industries Limited, a listed company with a turnover of 1,200 crores. His profile highlights leadership in financial restructuring, treasury management, and cost optimization.

The company also informed exchanges of changes to its key managerial personnel authorized for determining materiality for disclosure of events. Ashish Desai is now included among the authorized KMPs, alongside Rajiv Gandhi (CEO & managing director), Priya Gandhi (executive director), and Vinod Mali (company secretary & compliance officer), who will also serve as a single point of contact for Regulation 30(5) matters.